StonvexLoading…
StonvexStonvexStonvexCore line items from AMGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $8.62B | $36.75B | $26.89B | $17.33B |
Operating Income | $2.67B | $9.08B | $6.36B | $3.83B |
Net Income | $1.82B | $7.71B | $6.38B | $3.16B |
EPS (Diluted) | $3.34 | $14.23 | $11.77 | $5.84 |
Total Assets | $92.50B | $90.59B | $90.14B | $87.90B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $12.04B | $9.13B | $9.45B | $8.03B |
Free Cash Flow OCF − CapEx | $1.48B | $8.10B | $7.14B | $2.89B |
Shares Outstanding | 539.70M | 538.80M | 538.50M | 538.30M |